BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 174 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $146,000 | -38.1% | 967 | -40.4% | 0.01% | -44.4% |
| Q2 2022 | $236,000 | +18.0% | 1,622 | -4.0% | 0.01% | +28.6% |
| Q1 2022 | $200,000 | +70.9% | 1,690 | +39.8% | 0.01% | +75.0% |
| Q2 2021 | $117,000 | +60.3% | 1,209 | +20.7% | 0.00% | -50.0% |
| Q2 2020 | $73,000 | -65.9% | 1,002 | -79.5% | 0.01% | -86.4% |
| Q2 2019 | $214,000 | +39.9% | 4,883 | +64.3% | 0.06% | -1.7% |
| Q1 2019 | $153,000 | +183.3% | 2,972 | +103.4% | 0.06% | +140.0% |
| Q4 2018 | $54,000 | +285.7% | 1,461 | +279.5% | 0.02% | +400.0% |
| Q3 2018 | $14,000 | -56.2% | 385 | -67.6% | 0.01% | -79.2% |
| Q4 2017 | $32,000 | +540.0% | 1,187 | +534.8% | 0.02% | +380.0% |
| Q2 2017 | $5,000 | – | 187 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |